Supernus Pharmaceuticals (SUPN) Tax Rate (2011 - 2025)
Supernus Pharmaceuticals (SUPN) reported Tax Rate of 115.99% for Q4 2025, down 15789.0% year-over-year from N/an in Q4 2024, and down 623.64% quarter-over-quarter from 22.15% in Q3 2025.
Supernus Pharmaceuticals (SUPN) Tax Rate (2011 - 2025) Analysis & Trends
Supernus Pharmaceuticals (SUPN) has 12 years of Tax Rate data on file, last reported at 115.99% in Q4 2025.
- Tax Rate for Q4 2025 came in at 115.99%, down 15789.0% year-over-year; the trailing twelve-month figure through Dec 2025 was 21.32% (down 318.0% YoY), and the FY2025 annual result was 21.37%, down 315.0% from the prior year.
- Tax Rate slipped to 115.99% in Q4 2025 per SUPN's latest filing, from 22.15% in the prior quarter.
- Over five years, Tax Rate peaked at 493.92% in Q3 2022 and troughed at 115.99% in Q4 2025.
- A 5-year average of 35.45% and a median of 24.19% in 2024 frame the typical range for Tax Rate.
- The sharpest annual moves came in 2022 and 2024: Tax Rate soared 46837 bps in 2022, then tumbled 24767 bps in 2024.
- A 5-year view of Tax Rate shows it stood at 19.06% in 2021, then jumped by 244 bps to 27.41% in 2022, then plunged by 154 bps to 14.85% in 2023, then soared by 382 bps to 41.9% in 2024, then slumped by 377 bps to 115.99% in 2025.
- Business Quant data shows SUPN's Tax Rate at 115.99% in Q4 2025, 22.15% in Q3 2025, and 34.98% in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Tax Rate (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 15.33% |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 20.71% |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 13.63% |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | -20.44% |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 19.81% |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 34.48% |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | -7.43% |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 24.29% |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | 9.29% |
| 10 | Supernus Pharmaceuticals | 2.57 Bn | 2.19 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -115.99% |
| Dec 31, 2025 | -115.99% |
| Sep 30, 2025 | 22.15% |
| Sep 30, 2025 | 22.15% |
| Jun 30, 2025 | -34.98% |
| Jun 30, 2025 | -34.98% |
| Mar 31, 2025 | -102.83% |
| Mar 31, 2025 | -102.83% |
| Dec 31, 2024 | 41.90% |
| Dec 31, 2024 | 41.90% |
| Sep 30, 2024 | 14.24% |
| Sep 30, 2024 | 14.24% |
| Jun 30, 2024 | 24.33% |
| Jun 30, 2024 | 24.33% |
| Mar 31, 2024 | 48.97% |
| Mar 31, 2024 | 48.97% |
| Dec 31, 2023 | -14.85% |
| Dec 31, 2023 | -14.85% |
| Sep 30, 2023 | 261.91% |
| Sep 30, 2023 | 261.91% |